HYUNDAI PHARMACEUTICAL (004310) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, HYUNDAI PHARMACEUTICAL (004310) reported revenue of 191.8 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025191.8 billion KRW4.2 billion KRW2.5 billion KRW[source]
2024175.7 billion KRW181 million KRW-575 million KRW[source]
2023180.8 billion KRW6.9 billion KRW6.1 billion KRW[source]
2022162.7 billion KRW8.0 billion KRW-165 million KRW[source]
2021139.8 billion KRW-1.6 billion KRW-3.2 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025163.2 billion KRW81.1 billion KRW82.1 billion KRW[source]
2024156.4 billion KRW77.3 billion KRW79.1 billion KRW[source]
2023154.6 billion KRW70.0 billion KRW84.7 billion KRW[source]
2022181.2 billion KRW94.6 billion KRW86.6 billion KRW[source]
2021163.9 billion KRW77.3 billion KRW86.6 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice